Goodwin advised TCR2 Therapeutics on the completion of its highly oversubscribed $125 million Series B financing round. Proceeds of the financing will be used to advance…
TCR2 Therapeutics’ $125 Million Series B Financing

Goodwin advised TCR2 Therapeutics on the completion of its highly oversubscribed $125 million Series B financing round. Proceeds of the financing will be used to advance…